Inventor · disambiguated record
Scott D. Bembenek
Also filed as: BEMBENEK SCOTT · BEMBENEK SCOTT D · BEMBENEK SCOTT DAMIAN
11 granted patents·6 pending applications·36 citations·filing 2004–2024
87Inventor score
Top patents by PatentIndex Score
17 records- 0191US12065446B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Aug 20, 2024·1 cites·4 claims
- 0291US10717745B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 21, 2020·5 cites·26 claims
- 0390US10934310B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 2, 2021·4 cites·7 claims
- 0486US2024383914A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0584US11319329B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·7 claims
- 0684US7935725B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2008·Granted May 3, 2011·6 cites·16 claims
- 0781US8367719B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Feb 5, 2013·5 cites·21 claims
- 0879US8937078B2Quinazolinones as prolyl hydroxylase inhibitorsBEMBENEK SCOTT D·Filed 2010·Granted Jan 20, 2015·9 cites·13 claims
- 0979US8344008B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A ydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Jan 1, 2013·5 cites·4 claims
- 1065US10800792B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 13, 2020·0 cites·4 claims
- 1164US10822348B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 3, 2020·0 cites·10 claims
- 1258US10689396B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jun 23, 2020·0 cites·23 claims
- 1358US2024376085A1Benzimidazoles as modulators of il-17JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1452US2005043378A1LTA4H modulatorsFiled 2004·Application pending·0 cites
- 1552US2005043379A1LTA4H ModulatorsFiled 2004·Application pending·0 cites
- 1650US2015291593A1Novel heteroaryl and heterocycle compounds, compositions and methodsHUTCHISON MEDIPHARMA LTD·Filed 2013·Application pending·0 cites
- 1749US2015307520A1Novel heteroaryl and heterocycle compounds, compositions and methods thereofHUTCHISON MEDIPHARMA LTD·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →